-
Part 1 | Session 1 What's Hot at AHA22? Late-Breaking Science Wrap-up
-
Part 1 | Session 2 What's Hot at AHA22? Late-Breaking Science Preview
-
Part 2 | Session 1 The TRANSFORM-HF Trial WIth Dr Van Spall & Dr Mentz
-
Part 2 | Session 2 The STRONG-HF Trial With Dr Van Spall & Prof Mebazaa
-
Part 2 | Session 3 The PRECISE Trial With Dr Van Spall & Dr Douglas
-
Part 3 | Session 2 EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation
-
Part 3 | Session 3 BT001 PIVOTAL: nCBT in Pts with Type II Diabetes
-
Part 3 | Session 4 PRECISION: Aprocitentan in the Treatment of Resistant Hypertension
-
Part 3 | Session 7 SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension
-
Part 4 | Session 1 The PROMINENT Trial With Dr Kaur & Dr Pradhan
-
Part 4 | Session 2 The OCEAN(a)-DOSE Trial With Dr Gurleen Kaur & Dr Michelle L O'Donoghue
-
Part 4 | Session 3 The EMPA-Kidney Trial With Dr Wilcox & Dr Preiss
-
Part 4 | Session 4 The PREVENT-HD Randomized Clinical Trial With Dr Fadah & Dr Piazza
-
Part 4 | Session 5 The RESPECT EPA Trial With Prof Daida & Dr Jumkhawala
-
Part 4 | Session 6 The PROGRESSIVE-AF Trial With Dr Wilcox & Dr Andrade
-
Part 4 | Session 7 The ECMO-CS Trial With Dr Ostadal & Dr Jumkhawala
-
Part 4 | Session 8 The IRONMAN Trial With Dr Amir & Dr Kalra
-
Part 5 | Session 1 Being a Researcher With Investigator, Dr Julian Gillmore
-
Part 5 | Session 2 Research in 2022 With Investigator, Dr Shino Kany
-
Part 5 | Session 3 Making a Difference With Physician-Scientist, Dr Schlaich
-
Part 5 | Session 4 What Makes Dr Bonaca excited about CV Science in 2022?
-
Part 6 | Session 1 Late-breaking Science Highlights With Dr Joseph A Hill
Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews.
With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View from the Thoraxcenter.
Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.
This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.
Look behind the scientific achievement and learn more about the personal motivations of some of the investigators, benefit from their advice for early career researchers through our Behind the Heart series.
More from this programme
Part 1
View from the Thoraxcenter: Review Series
Part 2
Late-breaker Discussions With Harriette Van Spall
Part 3
Expert Interviews
Part 4
Radcliffe & CardioNerds @AHA22
Part 5
Behind the Heart
Part 6
AHA22 Highlights
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.
Academic History
Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…